Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Alzrigat

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
RNA & Disease (Houston, Tex.)|July 1, 2017
The miR-125a and miR-320c are potential tumor suppressor microRNAs epigenetically silenced by the polycomb repressive complex 2 in multiple myelomaMohammad Alzrigat, Helena Jernberg-Wiklund
Epigenomes|February 15, 2019
Targeting EZH2 in Multiple Myeloma-Multifaceted Anti-Tumor ActivityMohammad Alzrigat, Helena Jernberg-Wiklund, Jonathan D Licht
Seminars in Cancer Biology|October 1, 2017
Epigenetics in multiple myeloma: From mechanisms to therapyMohammad Alzrigat, Alba Atienza Párraga, Helena Jernberg-Wiklund
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2021
Methods to Study Myc-Regulated Cellular Senescence: An UpdateFan Zhang, Wesam Bazzar, Mohammad Alzrigat, et al.
International Journal of Molecular Sciences|May 13, 2023
MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in NeuroblastomaPrasoon Agarwal, Aleksandra Glowacka, Loay Mahmoud, et al.
Cell Cycle (Georgetown, Tex.)|December 28, 2020
Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescenceWesam Bazzar, Matteo Bocci, Eduar Hejll, et al.
Scientific Reports|February 5, 2026
CDK2 inhibition promotes neuronal differentiation in neuroblastomaMohammad Alzrigat, Loay Mahmoud, Ada Nursel Topçu, et al.
The Journal of Cell Biology|September 26, 2012
PML promotes MHC class II gene expression by stabilizing the class II transactivatorTobias Ulbricht, Mohammad Alzrigat, Almut Horch, et al.
Cancers|September 28, 2023
Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal DevelopmentYe Yuan, Mohammad Alzrigat, Aida Rodriguez-Garcia, et al.
Redox Biology|July 2, 2025
The inhibition of TXNRD1 by methylglyoxal impairs the intracellular control of Mycobacterium tuberculosisHanxiong Li, Ruining Liu, Gokul Raj Kathamuthu, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
RNA & Disease (Houston, Tex.)|July 1, 2017
The miR-125a and miR-320c are potential tumor suppressor microRNAs epigenetically silenced by the polycomb repressive complex 2 in multiple myelomaMohammad Alzrigat, Helena Jernberg-Wiklund
Epigenomes|February 15, 2019
Targeting EZH2 in Multiple Myeloma-Multifaceted Anti-Tumor ActivityMohammad Alzrigat, Helena Jernberg-Wiklund, Jonathan D Licht
Seminars in Cancer Biology|October 1, 2017
Epigenetics in multiple myeloma: From mechanisms to therapyMohammad Alzrigat, Alba Atienza Párraga, Helena Jernberg-Wiklund
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2021
Methods to Study Myc-Regulated Cellular Senescence: An UpdateFan Zhang, Wesam Bazzar, Mohammad Alzrigat, et al.
International Journal of Molecular Sciences|May 13, 2023
MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in NeuroblastomaPrasoon Agarwal, Aleksandra Glowacka, Loay Mahmoud, et al.
Cell Cycle (Georgetown, Tex.)|December 28, 2020
Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescenceWesam Bazzar, Matteo Bocci, Eduar Hejll, et al.
Scientific Reports|February 5, 2026
CDK2 inhibition promotes neuronal differentiation in neuroblastomaMohammad Alzrigat, Loay Mahmoud, Ada Nursel Topçu, et al.
The Journal of Cell Biology|September 26, 2012
PML promotes MHC class II gene expression by stabilizing the class II transactivatorTobias Ulbricht, Mohammad Alzrigat, Almut Horch, et al.
Cancers|September 28, 2023
Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal DevelopmentYe Yuan, Mohammad Alzrigat, Aida Rodriguez-Garcia, et al.
Redox Biology|July 2, 2025
The inhibition of TXNRD1 by methylglyoxal impairs the intracellular control of Mycobacterium tuberculosisHanxiong Li, Ruining Liu, Gokul Raj Kathamuthu, et al.
Pageof 2